HOOKIPA Pharma
HOOK
HOOK was delisted on the 7th of August, 2025.
45 hedge funds and large institutions have $16.4M invested in HOOKIPA Pharma in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 11 closing their positions.
130% more call options, than puts
Call options by funds: $69K | Put options by funds: $30K
0.3% less ownership
Funds ownership: 4.55% → 4.25% (-0.3%)
15% less capital invested
Capital invested by funds: $19.2M → $16.4M (-$2.9M)
18% less funds holding
Funds holding: 55 → 45 (-10)
40% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 15
91% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$224K |
| 2 |
Morgan Stanley
New York
|
+$191K |
| 3 |
VF
Virtu Financial
New York
|
+$55.8K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$34.7K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$20.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$1M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$503K |
| 3 |
Millennium Management
New York
|
-$65.6K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$36.5K |
| 5 |
OQS
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
|
-$30.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SG
51
StoneX Group
New York
| – | -$8.62K | -1,064 | Closed |
|
52
Rockefeller Capital Management
New York
| – | -$1K | -203 | Closed |
|
|
NA
53
NewEdge Advisors
New Orleans,
Louisiana
| – | -$134 | -17 | Closed |
|
|
IRC
54
Investors Research Corp
Atlanta,
Georgia
| – | -$65 | -8 | Closed |
|
HOOK Hedge Fund Activity: Q1 2023 in Review
45 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q1 2023, worth a combined $16.4M — down 15% from $19.2M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of HOOK and 1 opened new positions — a net loss of 10 holders — while 15 trimmed existing stakes and 9 added.
The largest buyer was Knoll Capital Management, adding an estimated $224K. The largest seller was Deep Track Capital, exiting entirely with an estimated $1M sold.
- 45 institutional investors held HOOKIPA Pharma (HOOK) as of Q1 2023, down from 55 in Q4 2022.
- Funds reported $16.4M of HOOKIPA Pharma stock for Q1 2023, down 15% quarter-over-quarter.
- 1 fund opened new HOOKIPA Pharma positions in Q1 2023 and 11 closed out, a net change of -10 holders.
- The largest HOOKIPA Pharma buyer in Q1 2023 was Knoll Capital Management, an estimated $224K added.
- The largest HOOKIPA Pharma seller in Q1 2023 was Deep Track Capital, an estimated $1M sold.
Based on aggregated 13F filings for Q1 2023.